ST

Stille ABFNSE Stille Stock Report

Last reporting period 31 Dec, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0.185

Micro

Exchange

FNSE - First North Sweden

STIL.ST Stock Analysis

ST

Uncovered

Stille AB is uncovered by Eyestock quantitative analysis.

Market cap $B

0.185

Dividend yield

1.57 %

Shares outstanding

5.013 B

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

View Section: Eyestock Rating